| 1 | Ear Neoplasms | 38.6% |
| 2 | Nasopharyngitis | 31.7% |
| 3 | Laryngeal neoplasm | 30.2% |
| 4 | Pharyngitis | 28.1% |
| 5 | Nose Neoplasms | 26.3% |
| 6 | Paranasal Sinus Neoplasms | 21.6% |
| 7 | Tonsillitis | 20.5% |
| 8 | Lemierre Syndrome | 18.8% |
| 9 | Deglutition Disorders | 18.5% |
| 10 | Nasopharyngeal Neoplasms | 18.2% |
| 11 | Retropharyngeal Abscess | 17.8% |
| 12 | Maxillary Sinus Neoplasms | 17.7% |
| 13 | Ear Diseases | 17.3% |
| 14 | Mouth Neoplasms | 16.8% |
| 15 | Laryngeal Diseases | 14.7% |
| 16 | Nose Diseases | 14.7% |
| 17 | Peritonsillar Abscess | 14.6% |
| 18 | Acoustic Neuroma | 14.4% |
| 19 | Nasopharyngeal carcinoma | 14.1% |
| 20 | Labyrinthitis | 13.7% |
| 21 | Parathyroid Neoplasms | 13% |
| 22 | Thyroid Neoplasm | 13% |
| 23 | Thyroid carcinoma | 13% |
| 24 | Salivary Gland Neoplasms | 12.6% |
| 25 | Tongue Neoplasms | 12.6% |
| 26 | Tracheal Neoplasms | 11.6% |
| 27 | Otosclerosis | 11.2% |
| 28 | Tympanosclerosis | 11.2% |
| 29 | Primary Ciliary Dyskinesia | 10.7% |
| 30 | Parotid Neoplasms | 10.6% |
| 31 | Abdominal Neoplasms | 10.5% |
| 32 | Soft Tissue Neoplasms | 10.5% |
| 33 | Thoracic Neoplasms | 10.5% |
| 34 | Palatal Neoplasms | 10.2% |
| 35 | Esophageal Neoplasms | 10.2% |
| 36 | Leukoplakia, Oral | 9.7% |
| 37 | Tympanic Membrane Perforation | 9.6% |
| 38 | Herpes Zoster Oticus | 9.4% |
| 39 | Granuloma, Lethal Midline | 9.4% |
| 40 | Laryngeal Edema | 9.4% |
| 41 | Nose Deformities, Acquired | 9.4% |
| 42 | Otomycosis | 9.4% |
| 43 | Congenital Microtia | 9.4% |
| 44 | Digestive System Neoplasms | 9% |
| 45 | Endocrine Gland Neoplasms | 9% |
| 46 | Eye Neoplasms | 9% |
| 47 | Nervous System Neoplasms | 9% |
| 48 | Bone neoplasms | 8.8% |
| 49 | Skin Neoplasms | 8.8% |
| 50 | Hematologic Neoplasms | 8.8% |
| 51 | Splenic Neoplasms | 8.7% |
| 52 | Mouth Diseases | 8.6% |
| 53 | Tooth Diseases | 8.6% |
| 54 | Thyroid Nodule | 8.4% |
| 55 | Cochlear Diseases | 8.3% |
| 56 | Otitis Externa | 8.3% |
| 57 | Otitis Media | 8.3% |
| 58 | Vestibular Diseases | 8.3% |
| 59 | Endolymphatic Hydrops | 8.3% |
| 60 | Tooth Loss | 8.1% |
| 61 | Laryngitis | 8% |
| 62 | Rhinitis | 8% |
| 63 | Vocal Cord Dysfunction | 8% |
| 64 | Laryngostenosis | 8% |
| 65 | Mouth Abnormalities | 8% |
| 66 | Nasal Polyps | 8% |
| 67 | Dysacusis | 7.8% |
| 68 | Peritoneal Neoplasms | 7.8% |
| 69 | Jaw Diseases | 7.4% |
| 70 | Pharyngeal Diseases | 7.4% |
| 71 | Multiple Endocrine Neoplasia | 7.3% |
| 72 | Choanal Atresia | 7% |
| 73 | Voice Disorders | 7% |
| 74 | Voice Disturbance | 7% |
| 75 | Laryngocele | 7% |
| 76 | Paraneoplastic Encephalomyelitis | 7% |
| 77 | Pharyngeal Neoplasms | 7% |
| 78 | Pancreatic Neoplasm | 6.9% |
| 79 | Vestibulocochlear Nerve Diseases | 6.9% |
| 80 | Eyelid Neoplasms | 6.9% |
| 81 | Epistaxis | 6.9% |
| 82 | Facial Hemiatrophy | 6.9% |
| 83 | Melkersson-Rosenthal Syndrome | 6.9% |
| 84 | Mammary Neoplasms, Experimental | 6.9% |
| 85 | Croup | 6.9% |
| 86 | Rhinitis, Vasomotor | 6.9% |
| 87 | Meniere Disease | 6.8% |
| 88 | Otitis Media with Effusion | 6.8% |
| 89 | Temporomandibular Joint Disorders | 6.6% |
| 90 | Hamartoma | 6.5% |
| 91 | Neoplasms, Hormone-Dependent | 6.5% |
| 92 | Neoplasms, Multiple Primary | 6.5% |
| 93 | Paraneoplastic Syndromes | 6.5% |
| 94 | Precancerous Conditions | 6.5% |
| 95 | Neoplasms, Second Primary | 6.5% |
| 96 | Acanthoma | 6.2% |
| 97 | Retroperitoneal Neoplasms | 6.2% |
| 98 | Radicular Cyst | 6.2% |
| 99 | Laryngomalacia | 6.2% |
| 100 | Granuloma, Laryngeal | 6.2% |
| 101 | Vocal Cord Paralysis | 6.1% |
| 102 | Bell Palsy | 6% |
| 103 | Sinusitis | 5.9% |
| 104 | Cleft Palate | 5.9% |
| 105 | Laryngospasm | 5.9% |
| 106 | Dental Enamel Hypoplasia | 5.8% |
| 107 | Hypodontia | 5.8% |
| 108 | Macrostomia | 5.8% |
| 109 | Microstomia | 5.8% |
| 110 | Salivary Gland Fistula | 5.8% |
| 111 | Hyperacusis | 5.8% |
| 112 | Tinnitus | 5.8% |
| 113 | Phonophobia | 5.8% |
| 114 | Hearing Loss | 5.8% |
| 115 | Vestibular Neuronitis | 5.7% |
| 116 | Gingival Recession | 5.6% |
| 117 | Parotitis | 5.6% |
| 118 | Gingival Atrophy | 5.6% |
| 119 | Giant Cell Epulis | 5.6% |
| 120 | Bruxism | 5.6% |
| 121 | Burning Mouth Syndrome | 5.6% |
| 122 | Dental Leakage | 5.6% |
| 123 | Hypercementosis | 5.6% |
| 124 | Lip Diseases | 5.6% |
| 125 | Malocclusion | 5.6% |
| 126 | Microglossia | 5.6% |
| 127 | Oral Submucous Fibrosis | 5.6% |
| 128 | Periodontal Diseases | 5.6% |
| 129 | Salivary Gland Diseases | 5.6% |
| 130 | Stomatitis | 5.6% |
| 131 | Tongue Diseases | 5.6% |
| 132 | Tooth Crowding | 5.6% |
| 133 | Tooth Discoloration | 5.6% |
| 134 | Tooth Demineralization | 5.6% |
| 135 | Oral Ulcer | 5.6% |
| 136 | Tooth Ankylosis | 5.6% |
| 137 | Cyst | 5.4% |
| 138 | Neoplastic Processes | 5.4% |
| 139 | Neoplastic Syndromes, Hereditary | 5.4% |
| 140 | Pregnancy Complications, Neoplastic | 5.4% |
| 141 | Neoplasms, Experimental | 5.3% |
| 142 | Gingival Hemorrhage | 5.3% |
| 143 | Carcinoma, Lobular | 5.2% |
| 144 | Central Nervous System Neoplasms | 5.2% |
| 145 | Vascular Neoplasms | 5.2% |
| 146 | Thymus Neoplasms | 5.2% |
| 147 | Genital Neoplasms, Female | 5.1% |
| 148 | Retrognathia | 5.1% |
| 149 | Breast Neoplasms, Male | 5.1% |
| 150 | Triple Negative Breast Neoplasms | 5.1% |
| 151 | Testicular Neoplasms | 5.1% |
| 152 | Aphonia | 5.1% |
| 153 | Dysphonia | 5.1% |
| 154 | Hypopharyngeal Neoplasms | 5.1% |
| 155 | Hypopharyngeal Cancer | 5.1% |
| 156 | Rhinoscleroma | 5% |
| 157 | Vertigo | 4.9% |
| 158 | Mastoiditis | 4.8% |
| 159 | Petrositis | 4.8% |
| 160 | Tooth Injuries | 4.8% |
| 161 | Deafness | 4.8% |
| 162 | Hearing Loss, Sudden | 4.8% |
| 163 | Hearing Loss, Bilateral | 4.8% |
| 164 | Hearing Loss, High-Frequency | 4.8% |
| 165 | Hearing Loss, Mixed Conductive-Sensorineural | 4.8% |
| 166 | Hearing Loss, Unilateral | 4.8% |
| 167 | Complete Hearing Loss | 4.8% |
| 168 | Deaf Mutism | 4.8% |
| 169 | Jaw Abnormalities | 4.8% |
| 170 | Prognathism | 4.7% |
| 171 | Facial Nerve Diseases | 4.7% |
| 172 | Maxillary Diseases | 4.7% |
| 173 | Tooth Resorption | 4.7% |
| 174 | Granulomatosis, Orofacial | 4.7% |
| 175 | Oral candidiasis | 4.6% |
| 176 | Oral Fistula | 4.6% |
| 177 | Toothache | 4.6% |
| 178 | Lichen Planus, Oral | 4.6% |
| 179 | Neoplasms, Radiation-Induced | 4.5% |
| 180 | Multiple Endocrine Neoplasia Type 1 | 4.5% |
| 181 | Adrenal Gland Neoplasms | 4.5% |
| 182 | Gastrointestinal Neoplasms | 4.5% |
| 183 | Genital Neoplasms, Male | 4.5% |
| 184 | Liver neoplasms | 4.5% |
| 185 | Uveal Neoplasms | 4.5% |
| 186 | Carcinoma, Pancreatic Ductal | 4.5% |
| 187 | Urologic Neoplasms | 4.4% |
| 188 | Meningioma | 4.4% |
| 189 | Sebaceous Gland Neoplasms | 4.4% |
| 190 | Spinal Neoplasms | 4.4% |
| 191 | Bone Marrow Neoplasms | 4.4% |
| 192 | Thymoma | 4.4% |
| 193 | Temporomandibular Joint Dysfunction Syndrome | 4.2% |
| 194 | Hay fever | 4.2% |
| 195 | Rhinitis, Allergic, Perennial | 4.2% |
| 196 | Tonsillar Neoplasms | 4.2% |
| 197 | Liver Neoplasms, Experimental | 4.2% |
| 198 | Cheilitis | 4.1% |
| 199 | Dental caries | 4.1% |
| 200 | Dental Plaque | 4.1% |
| 201 | Dental Pulp Calcification | 4.1% |
| 202 | Drooling | 4.1% |
| 203 | Gingival Diseases | 4.1% |
| 204 | Glossitis | 4.1% |
| 205 | Macroglossia | 4.1% |
| 206 | Periodontitis | 4.1% |
| 207 | Pulpitis | 4.1% |
| 208 | Sialadenitis | 4.1% |
| 209 | Sialometaplasia, Necrotizing | 4.1% |
| 210 | Sialorrhea | 4.1% |
| 211 | Aphthous Stomatitis | 4.1% |
| 212 | Tooth Erosion | 4.1% |
| 213 | Xerostomia | 4.1% |
| 214 | Glossoptosis | 4.1% |
| 215 | Peri-Implantitis | 4.1% |
| 216 | Carcinoma 256, Walker | 4.1% |
| 217 | Hoarseness | 4.1% |
| 218 | Carcinoma, Ehrlich Tumor | 4% |
| 219 | Dermoid Cyst | 4% |
| 220 | Carcinoma, Lewis Lung | 4% |
| 221 | Tuberous Sclerosis | 4% |
| 222 | Trophoblastic Neoplasms | 3.9% |
| 223 | Facial paralysis | 3.9% |
| 224 | Leukemia, Experimental | 3.9% |
| 225 | Facial Paresis | 3.9% |
| 226 | Hemifacial Spasm | 3.9% |
| 227 | Paraneoplastic Cerebellar Degeneration | 3.8% |
| 228 | Basal Cell Nevus Syndrome | 3.7% |
| 229 | Micrognathism | 3.7% |
| 230 | Pierre Robin Syndrome | 3.7% |
| 231 | Melanoma, Experimental | 3.5% |
| 232 | Erythroplasia | 3.5% |
| 233 | Follicular cyst | 3.5% |
| 234 | leukemia | 3.5% |
| 235 | Mucocele | 3.5% |
| 236 | Neoplasms, Germ Cell and Embryonal | 3.5% |
| 237 | Neoplasms, Glandular and Epithelial | 3.5% |
| 238 | Pilonidal Cyst | 3.5% |
| 239 | Thyroglossal Cyst | 3.5% |
| 240 | Synovial Cyst | 3.5% |
| 241 | Germ Cell Cancer | 3.5% |
| 242 | Aberrant Crypt Foci | 3.5% |
| 243 | Nephroblastoma | 3.5% |
| 244 | insulinoma | 3.5% |
| 245 | Tooth Avulsion | 3.5% |
| 246 | Leukemia, Radiation-Induced | 3.4% |
| 247 | Pituitary Adenoma | 3.4% |
| 248 | Pituitary Neoplasms | 3.4% |
| 249 | Vipoma | 3.4% |
| 250 | Dental Pulp Necrosis | 3.4% |
| 251 | Facial Neuralgia | 3.4% |
| 252 | Neuroectodermal Tumors | 3.4% |
| 253 | Gingivitis | 3.4% |
| 254 | Glossitis, Benign Migratory | 3.4% |
| 255 | Pericoronitis | 3.4% |
| 256 | Aggressive Periodontitis | 3.4% |
| 257 | Gingival Overgrowth | 3.4% |
| 258 | Maxillofacial Abnormalities | 3.4% |
| 259 | Sarcoma, Experimental | 3.4% |
| 260 | Dental Fistula | 3.4% |
| 261 | Meningeal Neoplasms | 3.4% |
| 262 | Oroantral Fistula | 3.4% |
| 263 | ovarian neoplasm | 3.4% |
| 264 | Gastrinoma | 3.4% |
| 265 | Glucagonoma | 3.4% |
| 266 | Neoplasms, Neuroepithelial | 3.4% |
| 267 | Gliomatosis cerebri | 3.4% |
| 268 | Kartagener Syndrome | 3.4% |
| 269 | Hepatocellular Adenoma | 3.4% |
| 270 | Limbic Encephalitis | 3.4% |
| 271 | Retinoblastoma | 3.4% |
| 272 | Auditory Perceptual Disorders | 3.3% |
| 273 | Gingival Hyperplasia | 3.1% |
| 274 | Gingival Hypertrophy | 3.1% |
| 275 | Lambert-Eaton Myasthenic Syndrome | 3.1% |
| 276 | Vesicular Stomatitis | 3% |
| 277 | Prolactinoma | 3% |
| 278 | Growth Hormone-Secreting Pituitary Adenoma | 3% |
| 279 | Lung Neoplasms | 3% |
| 280 | Pleural Neoplasms | 3% |
| 281 | Sleep Bruxism | 2.9% |
| 282 | Leukoplakia | 2.9% |
| 283 | Lymphocele | 2.9% |
| 284 | Pancreatic Cyst | 2.9% |
| 285 | Brain Neoplasms | 2.9% |
| 286 | Spinal Cord Neoplasms | 2.9% |
| 287 | Leydig Cell Tumor | 2.9% |
| 288 | Barrett Esophagus | 2.9% |
| 289 | Breast Cyst | 2.9% |
| 290 | Histiocytic Disorders, Malignant | 2.9% |
| 291 | Actinic keratosis | 2.9% |
| 292 | Mediastinal Cyst | 2.9% |
| 293 | Neoplasm Invasiveness | 2.9% |
| 294 | Neoplasm Metastasis | 2.9% |
| 295 | Neoplasm Recurrence, Local | 2.9% |
| 296 | Parovarian Cyst | 2.9% |
| 297 | Pericardial Cyst | 2.9% |
| 298 | Thymic Cyst | 2.9% |
| 299 | Carcinogenesis | 2.9% |
| 300 | Myxoid cyst | 2.9% |
| 301 | Metastasis | 2.9% |
| 302 | melanoma | 2.9% |
| 303 | Uterine Neoplasms | 2.9% |
| 304 | Vaginal Neoplasms | 2.9% |
| 305 | Vulvar Neoplasms | 2.9% |
| 306 | Uterine Cancer | 2.9% |
| 307 | Fallopian Tube Neoplasms | 2.9% |
| 308 | Optic Nerve Glioma | 2.9% |
| 309 | Alveolar Bone Loss | 2.8% |
| 310 | Carcinosarcoma | 2.8% |
| 311 | Hemangiosarcoma | 2.8% |
| 312 | Leukemia L1210 | 2.8% |
| 313 | Leukemia P388 | 2.8% |
| 314 | lymphangiosarcoma | 2.8% |
| 315 | Trigeminal Nerve Disorder | 2.8% |
| 316 | Opsoclonus-Myoclonus Syndrome | 2.8% |
| 317 | Lymphomatoid Granulomatosis | 2.7% |
| 318 | Choriocarcinoma | 2.7% |
| 319 | Behcet Syndrome | 2.7% |
| 320 | granulosa cell tumor | 2.7% |
| 321 | Carcinoma, Ovarian Epithelial | 2.7% |
| 322 | Medulloblastoma | 2.6% |
| 323 | Adenomatous Polyposis Coli | 2.6% |
| 324 | Mobius Syndrome | 2.6% |
| 325 | Central Nervous System Cysts | 2.6% |
| 326 | Sarcoma 180 | 2.5% |
| 327 | Bile Duct Neoplasms | 2.5% |
| 328 | gallbladder neoplasm | 2.5% |
| 329 | Intestinal Neoplasms | 2.5% |
| 330 | Penile Neoplasms | 2.5% |
| 331 | Prostatic Neoplasms | 2.5% |
| 332 | Stomach Neoplasms | 2.5% |
| 333 | Meningeal Carcinomatosis | 2.5% |
| 334 | Composite Lymphoma | 2.5% |
| 335 | Mumps | 2.5% |
| 336 | Trigeminal Neuralgia | 2.5% |
| 337 | Herpes Labialis | 2.5% |
| 338 | Polycythemia Vera | 2.5% |
| 339 | Myelitis, Transverse | 2.5% |
| 340 | Mesoblastic Nephroma | 2.5% |
| 341 | Lymphoma | 2.5% |
| 342 | Corpus Luteum Cyst | 2.4% |
| 343 | Ovarian Cysts | 2.4% |
| 344 | Leukemia, Plasma Cell | 2.4% |
| 345 | Adenoma, Acidophil | 2.4% |
| 346 | Ganglioneuroma | 2.4% |
| 347 | Glioma | 2.4% |
| 348 | Malignant Glioma | 2.4% |
| 349 | Basal cell carcinoma | 2.3% |
| 350 | Carcinoma, Papillary | 2.3% |
| 351 | Squamous cell carcinoma | 2.3% |
| 352 | Chondrosarcoma | 2.3% |
| 353 | Craniopharyngioma | 2.3% |
| 354 | Cystadenoma | 2.3% |
| 355 | leiomyosarcoma | 2.3% |
| 356 | liposarcoma | 2.3% |
| 357 | Mesothelioma | 2.3% |
| 358 | synovial sarcoma | 2.3% |
| 359 | Neuroectodermal Tumor, Melanotic | 2.3% |
| 360 | Angiomyolipoma | 2.3% |
| 361 | Clear Cell Sarcoma of Soft Tissue | 2.3% |
| 362 | Alveolar Soft Part Sarcoma | 2.3% |
| 363 | Neuroendocrine Tumors | 2.3% |
| 364 | Sarcoma, Myeloid | 2.3% |
| 365 | Carcinoma, Basal Cell | 2.3% |
| 366 | Facial Nerve Injuries | 2.2% |
| 367 | Bladder Neoplasm | 2.2% |
| 368 | Kidney Neoplasm | 2.2% |
| 369 | Ureteral Neoplasms | 2.2% |
| 370 | Urethral Neoplasms | 2.2% |
| 371 | Adrenocortical carcinoma | 2.2% |
| 372 | Bronchial Neoplasms | 2.2% |
| 373 | Ulcerative stomatitis | 2.2% |
| 374 | Multiple Pulmonary Nodules | 2.2% |
| 375 | Choledochal Cyst | 2.2% |
| 376 | Supratentorial Neoplasms | 2.2% |
| 377 | Carcinoid Tumor | 2.1% |
| 378 | Endometrial Neoplasms | 2.1% |
| 379 | Neurilemmoma | 2.1% |
| 380 | Hutchinson's Melanotic Freckle | 2.1% |
| 381 | Melanoma, Amelanotic | 2.1% |
| 382 | Peutz-Jeghers Syndrome | 2.1% |
| 383 | Adenoma | 2.1% |
| 384 | Ameloblastoma | 2.1% |
| 385 | Angiokeratoma | 2.1% |
| 386 | Carcinoma | 2.1% |
| 387 | Chordoma | 2.1% |
| 388 | Hemangioma | 2.1% |
| 389 | hemangiopericytoma | 2.1% |
| 390 | Lymphangioma | 2.1% |
| 391 | Mesenchymoma | 2.1% |
| 392 | Nevus | 2.1% |
| 393 | Teratoma | 2.1% |
| 394 | Hepatoblastoma | 2.1% |
| 395 | Mixed Tumor, Mullerian | 2.1% |
| 396 | Germinoma | 2.1% |
| 397 | Teratocarcinoma | 2.1% |
| 398 | Angiofibroma | 2.1% |
| 399 | Sarcoma | 2.1% |
| 400 | Epithelioma | 2.1% |
| 401 | Toxic Epidermal Necrolysis | 2% |
| 402 | Stevens-Johnson Syndrome | 2% |
| 403 | Renal Cell Carcinoma | 2% |
| 404 | Papillary Renal Cell Carcinoma | 2% |
| 405 | Cystadenocarcinoma | 2% |
| 406 | Fibrosarcoma | 2% |
| 407 | Osteosarcoma | 2% |
| 408 | Mucoepidermoid Carcinoma | 2% |
| 409 | Astrocytoma | 1.9% |
| 410 | Ependymoma | 1.9% |
| 411 | oligodendroglioma | 1.9% |
| 412 | Ganglioglioma | 1.9% |
| 413 | gliosarcoma | 1.9% |
| 414 | Anaplastic astrocytoma | 1.9% |
| 415 | Anaplastic Oligodendroglioma | 1.9% |
| 416 | Pleural Effusion, Malignant | 1.9% |
| 417 | Prostatic Neoplasms, Castration-Resistant | 1.9% |
| 418 | Endometrial Stromal Sarcoma | 1.9% |
| 419 | Nelson Syndrome | 1.9% |
| 420 | Adenofibroma | 1.8% |
| 421 | Fibroadenoma | 1.8% |
| 422 | Malignant Fibrous Histiocytoma | 1.8% |
| 423 | Brain Stem Neoplasms | 1.8% |
| 424 | Denys-Drash Syndrome | 1.8% |
| 425 | Malignant Carcinoid Syndrome | 1.8% |
| 426 | Carcinoma, Endometrioid | 1.7% |
| 427 | Pancreatic Pseudocyst | 1.7% |
| 428 | Plasmacytoma | 1.7% |
| 429 | Malignant histiocytosis | 1.7% |
| 430 | Lymphatic Metastasis | 1.7% |
| 431 | Neoplasms, Unknown Primary | 1.7% |
| 432 | Leukemic Infiltration | 1.7% |
| 433 | Histiocytic sarcoma | 1.7% |
| 434 | Neoplasm Micrometastasis | 1.7% |
| 435 | Bowen's Disease | 1.7% |
| 436 | Paraganglioma | 1.7% |
| 437 | Rhabdomyosarcoma | 1.7% |
| 438 | Giant Cell Tumor of Bone | 1.7% |
| 439 | Sicca Syndrome | 1.7% |
| 440 | Sjogren's Syndrome | 1.7% |
| 441 | Hydatidiform Mole | 1.7% |
| 442 | Lymphangioleiomyomatosis | 1.7% |
| 443 | Cecal Neoplasms | 1.7% |
| 444 | Duodenal Neoplasms | 1.7% |
| 445 | Glioblastoma | 1.7% |
| 446 | Neuroblastoma | 1.7% |
| 447 | Glioblastoma Multiforme | 1.7% |
| 448 | Choroid Plexus Papilloma | 1.6% |
| 449 | Cerebellar Neoplasms | 1.6% |
| 450 | Neurofibrosarcoma | 1.6% |
| 451 | Dermatofibrosarcoma | 1.5% |
| 452 | Dermatofibrosarcoma Protuberans | 1.5% |
| 453 | Ganglioneuroblastoma | 1.5% |
| 454 | Colorectal Neoplasms | 1.5% |
| 455 | Hodgkin Disease | 1.4% |
| 456 | Lymphoma, Non-Hodgkin | 1.4% |
| 457 | Polycystic Ovary Syndrome | 1.4% |
| 458 | Xeroderma Pigmentosum | 1.4% |
| 459 | Carcinoid Heart Disease | 1.4% |
| 460 | Pheochromocytoma | 1.4% |
| 461 | Alveolar rhabdomyosarcoma | 1.4% |
| 462 | Appendiceal Neoplasms | 1.4% |
| 463 | Colonic Neoplasms | 1.4% |
| 464 | Rectal Neoplasms | 1.4% |
| 465 | Adenocarcinoma | 1.4% |
| 466 | Carcinoma in Situ | 1.4% |
| 467 | Carcinoma, Transitional Cell | 1.4% |
| 468 | Phyllodes Tumor | 1.4% |
| 469 | Dysgerminoma | 1.4% |
| 470 | Hemangioendothelioma | 1.4% |
| 471 | Lipoma | 1.4% |
| 472 | Myoma | 1.4% |
| 473 | Myxoma | 1.4% |
| 474 | Neuroma | 1.4% |
| 475 | Papilloma | 1.4% |
| 476 | Pseudomyxoma Peritonei | 1.4% |
| 477 | Seminoma | 1.4% |
| 478 | Papillomatosis | 1.4% |
| 479 | Angiolipoma | 1.4% |
| 480 | Myelolipoma | 1.4% |
| 481 | Neoplasms, Bone Tissue | 1.4% |
| 482 | Neoplasms, Fibrous Tissue | 1.4% |
| 483 | Smooth Muscle Tumor | 1.4% |
| 484 | Adenomatosis, Pulmonary | 1.4% |
| 485 | Adenomatous Polyps | 1.4% |
| 486 | Carcinoma, Large Cell | 1.4% |
| 487 | Carcinoma, Small Cell | 1.4% |
| 488 | Desmoplastic Small Round Cell Tumor | 1.4% |
| 489 | Chondroma | 1.4% |
| 490 | Enchondroma | 1.4% |
| 491 | Primary amyloidosis | 1.3% |
| 492 | Leukemia, Myelomonocytic, Chronic | 1.1% |
| 493 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 1.1% |
| 494 | Anus Neoplasms | 1.1% |
| 495 | Sigmoid Neoplasms | 1.1% |
| 496 | Adenoid Cystic Carcinoma | 1% |
| 497 | fibroma | 1% |
| 498 | Fibromatosis | 1% |
| 499 | Osteoblastoma | 1% |
| 500 | Osteoma | 1% |
| 501 | Rhabdomyoma | 1% |
| 502 | Chondromatosis | 1% |
| 503 | Adenocarcinoma, Clear Cell | 1% |
| 504 | Cholangiocarcinoma | 1% |
| 505 | Cervical Intraepithelial Neoplasia | 1% |
| 506 | Hemangioblastoma | 1% |
| 507 | Lymphoma, Extranodal NK-T-Cell | 1% |
| 508 | Waldenstrom Macroglobulinemia | 1% |
| 509 | Multiple Myeloma | 1% |
| 510 | Mastocytosis | 1% |
| 511 | Sturge-Weber Syndrome | 1% |
| 512 | Cell Transformation, Viral | 1% |
| 513 | Gastrointestinal Stromal Tumors | 1% |
| 514 | Hemangioma, Cavernous | 1% |
| 515 | Leukemia, T-Cell | 1% |
| 516 | Leukemia, B-Cell | 1% |
| 517 | neurofibroma | 1% |
| 518 | Lymphoma, Follicular | 1% |
| 519 | T-Cell Lymphoma | 1% |
| 520 | Mantle cell lymphoma | 1% |
| 521 | Zollinger-Ellison syndrome | 0.9% |
| 522 | Fibromatosis, Aggressive | 0.9% |
| 523 | Fibromatosis, Abdominal | 0.9% |
| 524 | Klatskin Tumor | 0.9% |
| 525 | Mastocytoma | 0.8% |
| 526 | Mastocytosis, Systemic | 0.8% |
| 527 | Leukemia, Myeloid, Chronic-Phase | 0.8% |
| 528 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 0.7% |
| 529 | Leukemia, Large Granular Lymphocytic | 0.7% |
| 530 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 0.7% |
| 531 | Lymphoma, T-Cell, Cutaneous | 0.7% |
| 532 | Lymphoma, AIDS-Related | 0.7% |
| 533 | Enteropathy-Associated T-Cell Lymphoma | 0.7% |
| 534 | Primary Effusion Lymphoma | 0.7% |
| 535 | Dupuytren Contracture | 0.6% |
| 536 | Urticaria Pigmentosa | 0.6% |
| 537 | Mycosis Fungoides | 0.6% |
| 538 | Lymphomatoid Papulosis | 0.6% |
| 539 | Plasmablastic lymphoma | 0.6% |
| 540 | Burkitt Lymphoma | 0.6% |
| 541 | Sezary Syndrome | 0.5% |
